Iovance Biotherapeutics(IOVA) - 2021 Q2 - Quarterly Report

Table of Contents U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Commission File Number 001-36860 IOVANCE BIOTHERAPEUTICS, INC. (Exact name of issuer as specified in its charter) Delaware 75-3254381 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification number) 999 Skyway Road, Suite 150, San Carlos, CA 94070 (Address of principal executive offices and zip code) (650) 260-7120 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIE ...